momo-T/FIF Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : momo-T/FIF

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Tomato who wrote (429)	5/30/2004 5:19:49 PM
From: keokalani'nui	Read Replies (4) of 12215

I'd vote for 25%+ cash. At least enough to add ~4 positions. Rick--As for mygn's nsaid and me, I'm not expert enough to really have an informed idea. With my AB in English, I scrutinized the studies and, sure, I can see where they might get lucky. I was wrong to slam it as just another nsaid which clearly it is not (though at the time I think I was expressing not what I thought but what I thought the market thought). Today I really don't expect a robust effect in either indication. So I have just a minimal sliver of mygn--won't move the meter no matter what. Just to keep talking here, Arena looked very interesting to me, right up until I discovered the 12/03 preferred stock financing. Ugh, a self-inflicted wound. Some management should not be given live ammunition! Whatever were they thinking? Now they file a shelf to--I'm guessing--pay it off at lower prices 8 months later. No wonder the cfo resigned. :-( But no wonder lampert has kept a position. ;-)

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next